PT Phapros, Tbk (PEHA.JK)
IDR 270.0
(0.74%)
IDR 270.0
(0.74%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 5.95 Billion IDR | -78.77% |
| 2022 | 28.06 Billion IDR | 153.55% |
| 2021 | 11.07 Billion IDR | -77.17% |
| 2020 | 48.48 Billion IDR | -52.48% |
| 2019 | 102.03 Billion IDR | -22.88% |
| 2018 | 132.3 Billion IDR | 5.62% |
| 2017 | 125.26 Billion IDR | 43.98% |
| 2016 | 87 Billion IDR | 38.08% |
| 2015 | 63 Billion IDR | 39.01% |
| 2014 | 45.32 Billion IDR | 7.65% |
| 2013 | 42.1 Billion IDR | -39.12% |
| 2012 | 69.15 Billion IDR | 6.9% |
| 2011 | 64.69 Billion IDR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -20.02 Billion IDR | 32.0% |
| 2024 Q3 | -18.31 Billion IDR | 8.54% |
| 2024 Q1 | -29.44 Billion IDR | -239.41% |
| 2023 Q3 | -22.9 Billion IDR | -854.4% |
| 2023 Q2 | 3.03 Billion IDR | -35.53% |
| 2023 Q1 | 4.7 Billion IDR | -57.0% |
| 2023 Q4 | 21.11 Billion IDR | 192.21% |
| 2023 FY | 5.95 Billion IDR | -78.77% |
| 2022 FY | 28.06 Billion IDR | 153.55% |
| 2022 Q3 | 5.98 Billion IDR | 8.0% |
| 2022 Q2 | 5.53 Billion IDR | -1.09% |
| 2022 Q1 | 5.59 Billion IDR | 2855.44% |
| 2022 Q4 | 10.94 Billion IDR | 83.05% |
| 2021 Q1 | 7.15 Billion IDR | 570.64% |
| 2021 FY | 11.07 Billion IDR | -77.17% |
| 2021 Q4 | 189.47 Million IDR | -58.76% |
| 2021 Q3 | 459.45 Million IDR | -85.94% |
| 2021 Q2 | 3.26 Billion IDR | -54.34% |
| 2020 Q4 | -1.52 Billion IDR | -106.57% |
| 2020 FY | 48.48 Billion IDR | -52.48% |
| 2020 Q1 | -13.83 Billion IDR | -132.91% |
| 2020 Q2 | 40.71 Billion IDR | 394.26% |
| 2020 Q3 | 23.13 Billion IDR | -43.18% |
| 2019 Q3 | 12.24 Billion IDR | -71.3% |
| 2019 Q4 | 42.04 Billion IDR | 243.4% |
| 2019 FY | 102.03 Billion IDR | -22.88% |
| 2019 Q2 | 42.66 Billion IDR | 739.0% |
| 2019 Q1 | 5.08 Billion IDR | -86.1% |
| 2018 Q4 | 36.58 Billion IDR | -14.96% |
| 2018 Q1 | 12.46 Billion IDR | -76.58% |
| 2018 Q2 | 40.25 Billion IDR | 222.99% |
| 2018 FY | 132.3 Billion IDR | 5.62% |
| 2018 Q3 | 43.01 Billion IDR | 6.87% |
| 2017 Q4 | 53.2 Billion IDR | 0.0% |
| 2017 FY | 125.26 Billion IDR | 43.98% |
| 2016 FY | 87 Billion IDR | 38.08% |
| 2015 FY | 63 Billion IDR | 39.01% |
| 2014 FY | 45.32 Billion IDR | 7.65% |
| 2013 FY | 42.1 Billion IDR | -39.12% |
| 2012 FY | 69.15 Billion IDR | 6.9% |
| 2011 FY | 64.69 Billion IDR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 146.33 Billion IDR | 95.928% |
| PT Merck Tbk | 178.24 Billion IDR | 96.657% |
| PT Pyridam Farma Tbk | -85.22 Billion IDR | 106.993% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 950.64 Billion IDR | 99.373% |
| PT Tempo Scan Pacific Tbk | 1177.43 Billion IDR | 99.494% |